Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Search content at University of Arizona
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Sex-specific epigenetic programming in renal fibrosis and inflammation
Prerna Kumar
,
Heddwen L. Brooks
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Sex-specific epigenetic programming in renal fibrosis and inflammation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sex-specific
100%
Renal Inflammation
100%
Renal Fibrosis
100%
Epigenetic Programming
100%
Chronic Kidney Disease
66%
Renal Disease
66%
Epigenetic Modification
66%
Gene Expression
33%
Therapeutic Strategies
33%
Disease Treatment
33%
High Incidence
33%
Pathophysiology
33%
DNA Methylation (DNAm)
33%
Heart Disease
33%
Renal Failure
33%
Diabetes
33%
Obesity
33%
Sex Hormones
33%
Renal Function
33%
Sex Differences
33%
Cellular Response
33%
Epigenetic Modulation
33%
Renal Injury
33%
Aging Population
33%
Persistent Inflammation
33%
Renal Damage
33%
Renal Physiology
33%
Hypertension Prevalence
33%
Environmental Stimuli
33%
Epigenetic Therapy
33%
Hormonal Stimulation
33%
Histone Modification
33%
Putative Drug Targets
33%
Epigenetic Signal
33%
Intrinsic Signals
33%
Kidney Disease Progression
33%
Inflammatory Fibrosis
33%
Extrinsic Signals
33%
Medicine and Dentistry
Chronic Kidney Disease
100%
Nephritic Syndrome
100%
Kidney Fibrosis
100%
Nephropathy
66%
Kidney Injury
66%
Sex Difference
33%
Prevalence
33%
Heart Disease
33%
Pathophysiology
33%
Gene Expression
33%
Sex Hormone
33%
Diabetes
33%
Combination Therapy
33%
Kidney Function
33%
Renal Failure
33%
Fibrosis
33%
DNA Methylation
33%
Histone Modification
33%
Renal Physiology
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Kidney Fibrosis
100%
Nephritis
100%
Kidney Injury
66%
Kidney Disease
66%
Inflammation
33%
Prevalence
33%
Histone
33%
Combination Therapy
33%
Pathophysiology
33%
Heart Disease
33%
Kidney Failure
33%
Fibrosis
33%
Sex Hormone
33%